Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Dengue virus (DENV) is one of the major infectious pathogens worldwide. DENV infection is a highly dynamic process. Currently, no antiviral drug is available for treating DENV-induced diseases since little is known regarding how the virus interacts with host cells during infection. Advanced molecular imaging technologies are powerful tools to understand the dynamics of intracellular interactions and molecular trafficking. This study exploited a single-virus particle tracking technology to address whether DENV interacts with autophagy machinery during the early stage of infection. Using confocal microscopy and three-dimensional image analysis, we showed that DENV triggered the formation of green fluorescence protein-fused microtubule-associated protein 1A/1B-light chain 3 (GFP-LC3) puncta, and DENV-induced autophagosomes engulfed DENV particles within 15-min postinfection. Moreover, single-virus particle tracking revealed that both DENV particles and autophagosomes traveled together during the viral infection. Finally, in the presence of autophagy suppressor 3-methyladenine, the replication of DENV was inhibited and the location of DENV particles spread in cytoplasma. In contrast, the numbers of newly synthesized DENV were elevated and the co-localization of DENV particles and autophagosomes was detected while the cells were treated with autophagy inducer rapamycin. Taken together, we propose that DENV particles interact with autophagosomes at the early stage of viral infection, which promotes the replication of DENV.

Download full-text PDF

Source
http://dx.doi.org/10.1117/1.JBO.19.1.011018DOI Listing

Publication Analysis

Top Keywords

denv particles
20
early stage
12
denv
12
dengue virus
8
stage infection
8
single-virus particle
8
particle tracking
8
particles autophagosomes
8
viral infection
8
replication denv
8

Similar Publications

Comparative immunogenicity study of quartet and bifurcated tetravalent dengue virus envelope domain III displayed virus-like particle vaccine candidates in BALB/c mice.

Vaccine

August 2025

Molecular and Biological Function Research Core, Research Institute of Green Science and Technology, Shizuoka University, Ohya 836, Suruga-ku, Shizuoka 422-8529, Japan.; Laboratory of Biotechnology, Faculty of Agriculture, Shizuoka University, Ohya 836, Suruga-ku, Shizuoka 422-8529, Japan. Electroni

Developing an effective dengue vaccine requires targeting all four dengue virus (DENV) serotypes while ensuring both safety and efficacy. Our research aimed to address this by developing DENV vaccine candidates strategically designed to display Envelope Domain III (EDIII) antigens on a DENV capsid virus-like particle (VLP). We engineered tetravalent EDIII constructs, designed either as a quartet (qE) or bifurcated (bE) arrangement, and expressed them alongside DENV type 2 capsid (C2) in silkworm larvae, followed by affinity purification.

View Article and Find Full Text PDF

Antiviral effect of metformin and phenformin analogs against dengue in Huh-7 cells and AG129 mice.

Eur J Pharmacol

August 2025

Departamento de Infectómica y Patogénesis Molecular, Centro de Investigación y de Estudios Avanzados (Cinvestav), Ciudad de México, 07360, Mexico. Electronic address:

Dengue is a viral disease caused by the dengue virus (DENV), which continues to pose a significant global public health challenge. This concern is particularly heightened by the rising incidence of dengue over the last two decades. While many infected individuals experience mild symptoms, a subset can progress to severe dengue, characterized by life-threatening hemorrhagic complications.

View Article and Find Full Text PDF

Dengue virus (DENV), the etiological agent of dengue fever, remains a global health concern, leading to severe illness and death in the absence of any definitive cure. Research has shown that vitamin D may reduce DENV replication in vitro and that dengue patients with low or deficient vitamin D levels are at higher risk of severe dengue. Studies indicate that viral replication is inhibited in human monocyte-derived macrophages (MDM) differentiated in the presence of vitamin D (D3MDM), suggesting that vitamin D may prevent DENV entry into host cells.

View Article and Find Full Text PDF

Yunnan Province is an area in China with a major prevalence of biting arthropods (including mosquitos, ticks, and ) and arboviruses including dengue virus (DENV), bluetongue virus (BTV), and epizootic hemorrhagic disease virus (EHDV). Therefore, attempts to isolate and detect arboviruses are frequently conducted in Yunnan during the past decades. In this study, a total of three viral strains/isolates (LF6-4, LF3-1, and LF6C2) previously isolated from cattle, goat, and in Lufeng County, Yunnan Province, between 2022 and 2023 were used for whole-genome sequencing, phylogenetic analysis, and electron microscopic analysis.

View Article and Find Full Text PDF

Perennial endemics of mosquito-borne dengue infection affect millions of lives across tropical and subtropical regions every year. Factors like the Earth's rising temperature, climate change, and lack of dengue-specific drugs and vaccines have led to a significant surge in these infections, warranting urgent efforts to develop new antidengue agents. The dengue virus (DENV) envelope exposes approximately 90 E (envelope) protein dimers on its surface, making it a potent target for drug discovery and vaccine development.

View Article and Find Full Text PDF